UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents

Diabetes technology & therapeutics, 2020-11, Vol.22 (11), p.794-800

2020

Volltextzugriff (PDF)

Improvements in Parental Sleep, Fear of Hypoglycemia, and Diabetes Distress With Use of an Advanced Hybrid Closed-Loop System

Diabetes care, 2022-05, Vol.45 (5), p.1292-1295

2022

Volltextzugriff (PDF)

Friend or Foe: a Narrative Review of the Impact of Diabetes Technology on Sleep

Current diabetes reports, 2022-07, Vol.22 (7), p.283-290

2022

Volltextzugriff (PDF)

The future of telehealth in type 1 diabetes

Current opinion in endocrinology, diabetes, and obesity, 2022-08, Vol.29 (4), p.397-402

2022

Volltextzugriff (PDF)

Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions

Diabetes technology & therapeutics, 2024-09, Vol.26 (9), p.626-632

2024

Volltextzugriff (PDF)

1155-P: Seasonal Impact on Sleep and Glycemia in Adolescents with Type 1 Diabetes

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions

Diabetes technology & therapeutics, 2024-02, Vol.26 (2), p.119-124

2024

Volltextzugriff (PDF)

156-LB: Family Exposure and Impact of COVID-19 on a Pediatric T1D Population

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

146-LB: Impact of the COVID-19 Pandemic on Quality of Life in Youth with Type 1 Diabetes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

774-P: Impact of Transition to Tandem Control-IQ on Sleep Awakenings in Youth with Type 1 Diabetes (T1D) and Their Parents

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

147-LB: Effects of the COVID-19 Pandemic on Type 1 Diabetes Outcomes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

1118-P: Accuracy of Dexcom G6 Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Impact of 6-months of an advanced hybrid closed-loop system on sleep and psychosocial outcomes in youth with type 1 diabetes and their parents

Diabetes research and clinical practice, 2024-01, Vol.207, p.111087-111087, Article 111087

2024

Volltextzugriff (PDF)

157-LB: Association of Glycemic Ranges and Sleep Measures in Youth with T1D and Their Parents

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine

Diabetes technology & therapeutics, 2022-01, Vol.24 (1), p.67-74

2022

Volltextzugriff (PDF)

First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes

Diabetes technology & therapeutics, 2021-06, Vol.23 (6), p.410-424

2021

Volltextzugriff (PDF)

773-P: Impact of Six Months of Hybrid Closed-Loop Use on Sleep in Youth with Type 1 Diabetes and Their Parents

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Sleep in Type 1 Diabetes: Implications for Glycemic Control and Diabetes Management

Current diabetes reports, 2018-02, Vol.18 (2), p.5-8, Article 5

2018

Volltextzugriff (PDF)

Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes

Clinical diabetes, 2022-04, Vol.40 (2), p.253-256

2022

Volltextzugriff (PDF)

899-P: Patient Reported Outcomes (PROs) for Young Children Using the Control IQ Hybrid Closed-Loop System (CIQ)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

59-OR: Glycemic Control with Extended Use of Automated Insulin Delivery (AID) in Children Age 2–6 Years with Type 1 Diabetes (T1D)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System

Diabetes technology & therapeutics, 2021-07, Vol.23 (7), p.475-481

2021

Volltextzugriff (PDF)

Review of the Omnipod ® 5 Automated Glucose Control System Powered by Horizon™ for the treatment of Type 1 diabetes

Therapeutic delivery, 2020-08, Vol.11 (8), p.507-519

2020

Volltextzugriff (PDF)

1321-P: Lower Use of Technology in Youth with Type 1 Diabetes in Locations Distant from Specialty Care

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Frequency and Causes of Nocturnal Alarms in Youth and Young Adults With Type 1 Diabetes Using a First-Generation Hybrid Closed-Loop System

Diabetes spectrum, 2024-04, Vol.37 (2), p.118-123

2024

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(55)
Berichte
(1)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Diabetes
(36)
Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Humans
(30)
Endocrinology & Metabolism
(26)
Pediatrics
(26)
Diabetes Mellitus
(24)
Insulin
(22)
Child
(21)
Adolescent
(20)
Blood Glucose
(20)
Diabetes Mellitus, Type 1 - Drug Therapy
(19)
Sleep
(17)
Type 1 Diabetes
(17)
Hypoglycemia
(16)
Insulin Infusion Systems
(15)
Glucose
(13)
Hypoglycemic Agents - Therapeutic Use
(13)
Insulin - Therapeutic Use
(13)
Adult
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents

Improvements in Parental Sleep, Fear of Hypoglycemia, and Diabetes Distress With Use of an Advanced Hybrid Closed-Loop System

Friend or Foe: a Narrative Review of the Impact of Diabetes Technology on Sleep

The future of telehealth in type 1 diabetes

Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions

1155-P: Seasonal Impact on Sleep and Glycemia in Adolescents with Type 1 Diabetes

Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions

156-LB: Family Exposure and Impact of COVID-19 on a Pediatric T1D Population

146-LB: Impact of the COVID-19 Pandemic on Quality of Life in Youth with Type 1 Diabetes

774-P: Impact of Transition to Tandem Control-IQ on Sleep Awakenings in Youth with Type 1 Diabetes (T1D) and Their Parents

147-LB: Effects of the COVID-19 Pandemic on Type 1 Diabetes Outcomes

1118-P: Accuracy of Dexcom G6 Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions

Impact of 6-months of an advanced hybrid closed-loop system on sleep and psychosocial outcomes in youth with type 1 diabetes and their parents

157-LB: Association of Glycemic Ranges and Sleep Measures in Youth with T1D and Their Parents

Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine

First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes

773-P: Impact of Six Months of Hybrid Closed-Loop Use on Sleep in Youth with Type 1 Diabetes and Their Parents

Sleep in Type 1 Diabetes: Implications for Glycemic Control and Diabetes Management

Severe, Refractory Insulin Edema With Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent With Known Type 1 Diabetes

899-P: Patient Reported Outcomes (PROs) for Young Children Using the Control IQ Hybrid Closed-Loop System (CIQ)

59-OR: Glycemic Control with Extended Use of Automated Insulin Delivery (AID) in Children Age 2–6 Years with Type 1 Diabetes (T1D)

Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System

Review of the Omnipod ® 5 Automated Glucose Control System Powered by Horizon™ for the treatment of Type 1 diabetes

1321-P: Lower Use of Technology in Youth with Type 1 Diabetes in Locations Distant from Specialty Care

Frequency and Causes of Nocturnal Alarms in Youth and Young Adults With Type 1 Diabetes Using a First-Generation Hybrid Closed-Loop System

Suchergebnisse filtern